Please note - this is a temporary window. id21 is joining forces with Eldis and therefore the id21 website has been suspended. Soon all id21 content will be available on the Eldis website.
Delayed or inadequate malaria treatment increases the chance of severe disease and development of drug resistance. Chloroquine is a cheap and safe anti-malarial drug used widely throughout West Africa. Research by a District Health Management Team in Ghana shows that better communication and drug labelling increase patient adherence to chloroquine.
Inadequate treatment of malaria can result from:
Prescribers and dispensers do not always provide easy-to-understand information about the drugs, the duration of treatment or the ideal daily dose. This study evaluated the effect of improved drug labelling and verbal communication to patients with acute malaria on their adherence to oral chloroquine treatment.
The researchers created a two-day training programme for half of the prescribers, dispensers and their assistants in Dangme West - a rural district with a population of around 100 000. The other half did not receive the further training to provide a comparison for the study. They provided visual aids for educating clients about causes and prevention of malaria and pictorial stickers and rubber stamps for labelling drugs. They pre-tested these drawings in the community.
The researchers assessed the information provided to clients and the quality of drug labelling before and after the intervention. Adherence was assessed by a home-based interview with the client three days after their visit to the clinic. The researchers looked at 204 cases before the intervention and 197 cases afterwards. They found that:
The researchers point out that a one-off training programme does not usually cause a sustained change in provider behaviour and emphasise the need to:
Source(s):
‘Strategies to improve adherence to recommended chloroquine treatment
regimes: a quasi-experiment in the context of integrated primary health care
delivery in Ghana’, Social Science and Medicine 55: 2215-2226, by I. Agyepong
et al., 2002
HINARI subscribers can access the full-text article here. Full document.
Funded by: WHO TDR; Liverpool School of Tropical Medicine
id21 Research Highlight: 17 March 2003
Further Information:
Irene Akua Agyepong
District Health Administration
PO Box 1
Dodowa
Ghana
Fax:
+233 21 226739
Contact the contributor: iagyepong@ighmail.com
Liverpool School of Tropical Medicine (LSTM), UK
Other related links:
'Resisting change? Tackling drug-resistant malaria'
'All in the mix: combining malaria drugs to beat resistance in sub-Saharan
Africa'
See id21's collection of links relevant to infectious diseases.